These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21621023)

  • 1. From in silico target prediction to multi-target drug design: current databases, methods and applications.
    Koutsoukas A; Simms B; Kirchmair J; Bond PJ; Whitmore AV; Zimmer S; Young MP; Jenkins JL; Glick M; Glen RC; Bender A
    J Proteomics; 2011 Nov; 74(12):2554-74. PubMed ID: 21621023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools for in silico target fishing.
    Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Pujadas G; Garcia-Vallve S
    Methods; 2015 Jan; 71():98-103. PubMed ID: 25277948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the analysis of multiple activity profile of screening data using computational approaches.
    Kuyoc-Carrillo VF; Medina-Franco JL
    Drug Dev Res; 2014 Aug; 75(5):313-23. PubMed ID: 25160071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of computational methods in the identification of bioactive compounds.
    Glick M; Jacoby E
    Curr Opin Chem Biol; 2011 Aug; 15(4):540-6. PubMed ID: 21411361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating virtual screening in lead discovery.
    Oprea TI; Matter H
    Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint.
    Bender A; Young DW; Jenkins JL; Serrano M; Mikhailov D; Clemons PA; Davies JW
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):719-31. PubMed ID: 18045083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring polypharmacology using a ROCS-based target fishing approach.
    AbdulHameed MD; Chaudhury S; Singh N; Sun H; Wallqvist A; Tawa GJ
    J Chem Inf Model; 2012 Feb; 52(2):492-505. PubMed ID: 22196353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico methods to address polypharmacology: current status, applications and future perspectives.
    Lavecchia A; Cerchia C
    Drug Discov Today; 2016 Feb; 21(2):288-98. PubMed ID: 26743596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteochemometric modelling coupled to in silico target prediction: an integrated approach for the simultaneous prediction of polypharmacology and binding affinity/potency of small molecules.
    Paricharak S; Cortés-Ciriano I; IJzerman AP; Malliavin TE; Bender A
    J Cheminform; 2015; 7():15. PubMed ID: 25926892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.
    Ma XH; Shi Z; Tan C; Jiang Y; Go ML; Low BC; Chen YZ
    Pharm Res; 2010 May; 27(5):739-49. PubMed ID: 20221898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR and in silico screening.
    Rüdisser S; Jahnke W
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):591-603. PubMed ID: 12470256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the chemogenomic knowledge space with annotated chemical libraries.
    Savchuk NP; Balakin KV; Tkachenko SE
    Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacology: in silico methods of ligand design and development.
    McKie SA
    Future Med Chem; 2016 Apr; 8(5):579-602. PubMed ID: 27105127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand prediction from protein sequence and small molecule information using support vector machines and fingerprint descriptors.
    Geppert H; Humrich J; Stumpfe D; Gärtner T; Bajorath J
    J Chem Inf Model; 2009 Apr; 49(4):767-79. PubMed ID: 19309114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ; Meegan MJ; Carta G; Lloyd DG
    J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications.
    Bian Y; Xie XS
    AAPS J; 2018 Apr; 20(3):59. PubMed ID: 29633051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.